Modeling the cost-effectiveness of adjuvant osimertinib in resected EGFR-mutant non-small cell lung cancer patients.

被引：3
|
作者：
Lemmon, Christopher
Zabor, Emily Craig
Pennell, Nathan A.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.8527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8527
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
    Inomata, Minehiko
    Matsumoto, Masahiro
    Mizushima, Isami
    Hayashi, Kana
    Seto, Zenta
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kambara, Kenta
    Imanishi, Shingo
    Miwa, Toshiro
    Hayashi, Ryuji
    Matsui, Shoko
    Tobe, Kazuyuki
    [J]. EGYPTIAN JOURNAL OF BRONCHOLOGY, 2022, 16 (01)
  • [22] Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer
    Caressa Hui
    Vera Qu
    Jen-Yeu Wang
    Rie von Eyben
    Yu-Cheng Chang
    Po-Lin Chiang
    Chih-Hung Liang
    Jen-Tang Lu
    Gordon Li
    Melanie Hayden-Gephart
    Heather Wakelee
    Joel Neal
    Kavitha Ramchandran
    Millie Das
    Seema Nagpal
    Scott Soltys
    Nathaniel Myall
    Erqi Pollom
    [J]. Journal of Neuro-Oncology, 2022, 160 : 233 - 240
  • [23] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chiang, Chi-Lu
    Ho, Hsiang-Ling
    Yeh, Yi-Chen
    Lee, Cheng-Chia
    Huang, Hsu-Ching
    Shen, Chia-, I
    Luo, Yung-Hung
    Chen, Yuh-Min
    Chiu, Chao-Hua
    Chou, Teh-Ying
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (01) : 5 - 14
  • [24] Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
    Chi-Lu Chiang
    Hsiang-Ling Ho
    Yi-Chen Yeh
    Cheng-Chia Lee
    Hsu-Ching Huang
    Chia-I Shen
    Yung-Hung Luo
    Yuh-Min Chen
    Chao-Hua Chiu
    Teh-Ying Chou
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5 - 14
  • [25] Impact of sequential therapy with osimertinib on the overall survival in patients with EGFR-mutant non-small cell lung cancer
    Minehiko Inomata
    Masahiro Matsumoto
    Isami Mizushima
    Kana Hayashi
    Zenta Seto
    Kotaro Tokui
    Chihiro Taka
    Seisuke Okazawa
    Kenta Kambara
    Shingo Imanishi
    Toshiro Miwa
    Ryuji Hayashi
    Shoko Matsui
    Kazuyuki Tobe
    [J]. The Egyptian Journal of Bronchology, 2022, 16
  • [26] Adjuvant EGFR-TKIs for Patients With Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis of 1,283 Patients
    Chen, Rui-Lian
    Sun, Ling-Ling
    Cao, Yang
    Chen, Han-Rui
    Zhou, Jing-Xu
    Gu, Chu-Ying
    Zhang, Ying
    Wang, Si-Yu
    Hou, Wei
    Lin, Li-Zhu
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
    Rosell, Rafael
    Gonzalez-Cao, Maria
    Codony-Servat, Jordi
    Molina-Vila, Miguel Angel
    Mayo de las Casas, Clara
    Ito, Masaoki
    [J]. TRANSLATIONAL CANCER RESEARCH, 2023, 12 (03) : 456 - 460
  • [28] Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer
    Tozuka, Takehiro
    Noro, Rintaro
    Mizutani, Hideaki
    Kurimoto, Futoshi
    Hakozaki, Taiki
    Hisakane, Kakeru
    Naito, Tomoyuki
    Takahashi, Satoshi
    Taniuchi, Namiko
    Yajima, Chika
    Hosomi, Yukio
    Hirose, Takashi
    Minegishi, Yuji
    Okano, Tetsuya
    Kamio, Koichiro
    Yamaguchi, Tomoyoshi
    Seike, Masahiro
    [J]. LUNG CANCER, 2024, 191
  • [29] Phase I/II trial of dasatinib and osimertinib in patients with advanced EGFR-mutant non-small cell lung cancer
    Kim, Chul
    Liu, Stephen V.
    Subramaniam, Deepa Suresh
    Giaccone, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer
    Tian, Wentao
    Niu, Lishui
    Zhou, Rongrong
    Wang, Ziqi
    Ning, Jiaoyang
    Lu, Ruoyu
    Shi, Yin
    Tan, Zhaohua
    [J]. CANCER MEDICINE, 2024, 13 (16):
12345